← Leaderboards
Gary Liu
Massachusetts Institute Of Technology
$382,138
Attributed
$382,138
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $91.3K · FY2020–25$100K$75K$50K$25K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$382,138 · 2
By mechanism
F32$201,118 · 1
K99$181,020 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Robert S Langer$47,407,448
- Daniel John Siegwart$5,179,626
- Michael J Mitchell$3,277,478
- David E Root$4,631,439
- Phillip A Sharp$28,187,962
Others in their field
Other Emerging Leaders on “Prevent”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventPharmaceutical PreparationsLeadKnock-OutLipidsNanoparticle DeliveryGlucoseFlow CytometryIn VitroKidney FailureCellsLipid NanoparticleMacrophageMediatingDiabetes MellitusEndothelial CellsEngineeringExhibitsBioinformaticsIntravenousIn VivoKidneyBloodProperty
Grant awards (5)
New siRNA therapeutics to halt diabetic kidney disease$89,760
K99 · FY2025 · DK · contact PI
New siRNA therapeutics to halt diabetic kidney disease$91,260
K99 · FY2024 · DK · contact PI
Engineered nanoparticles to rescue complement dysfunction and vascular disease during diabetes$69,802
F32 · FY2022 · DK · contact PI
Engineered nanoparticles to rescue complement dysfunction and vascular disease during diabetes$66,390
F32 · FY2021 · DK · contact PI
Engineered nanoparticles to rescue complement dysfunction and vascular disease during diabetes$64,926
F32 · FY2020 · DK · contact PI